Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-01-01 @ 7:42 AM
Study NCT ID:
NCT00813956
Status:
COMPLETED
Last Update Posted:
2016-03-17
First Post:
2008-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12
Start Date Type:
None
Primary Completion Date:
2012-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-19
First Submit QC Date:
None
Study First Post Date:
2008-12-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-03-17
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-02-17
Last Update Post Date:
2016-03-17
Last Update Post Date Type:
ESTIMATED